Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Reviews on Cancer|August 10, 2025
GABAergic signaling in colorectal cancer: Mechanistic insights, tumor microenvironment crosstalk, and therapeutic opportunitiesDonghao Tang, Paola Orlandi, Qijie Li, et al.Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.Chemotherapy|August 7, 2023
Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case ReportMarta Banchi, Tiziana Lanzolla, Arianna Di Napoli, et al.Scientific Reports|April 2, 2025
Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Paola Orlandi, et al.Cancers|June 12, 2026
Prognostic Circulating Cytokine Panels for Metronomic Chemotherapy in Metastatic Gastrointestinal Cancer: Exploratory Pharmacodynamic Biomarker Analysis of the Phase II COMET TrialMaria Laura Manca, Paola Orlandi, Giacomo Allegrini, et al.Investigational New Drugs|January 17, 2025
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Arianna Bandini, et al.Investigational New Drugs|October 18, 2025
Synergistic combination of the adrenergic antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cellsArianna Bandini, Letizia Biso, Cristina Viaggi, et al.Journal of Clinical Medicine|February 26, 2025
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In VivoArianna Bandini, Marta Banchi, Paola Orlandi, et al.Journal of Clinical Medicine|October 29, 2025
Pharmacokinetics and Monitoring of Methotrexate in Adults with Acute Lymphoblastic Leukaemia: A 10-Year Follow-Up at an Italian CentrePasquale Fabio Calabrò, Letizia Biso, Marianna Lastella, et al.Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.Pageof 2